As bispecific antibodies emerge as therapeutic game changers, scientists leverage cutting-edge technologies to navigate their multifaceted development.
Cases of monkeypox are popping up across the globe. But where did it come from? How does it work? And how can we treat it? It took looking all the way back to the beginning — 1500 BCE to be exact — to answer these pressing questions.
As global regulations shift toward animal-free testing, how can researchers develop more biologically relevant in vitro models to advance drug discovery?